Health condition · Clinically reviewed
CNS vascular malformations, AVM, cavernoma, DVA, dAVF, vein of Galen and spinal lesions.
Six different lesions, one specialist pathway. A plain-English guide to how brain and spine vascular malformations are diagnosed and treated in the UK.
Why trust this guide
- 01
Clinically reviewed
Written by our editorial team and reviewed by a registered UK clinician before publication.
- 02
Sourced from guidance
Checked against NICE, BNSS, BSNR and peer-reviewed neurovascular sources you can see at the end.
- 03
Current for 2026
Reflects modern UK neurovascular practice including Gamma Knife, endovascular embolisation and genetic testing.
Key facts
CNS vascular malformations at a glance.
The six main types, the imaging that identifies them and the genetic conditions that group them into families.
-
What it is
A family of abnormal blood vessels in the brain or spinal cord. Six main types, each with its own risk profile and treatment path.
-
AVM
Arteriovenous malformation. Arteries feed directly into veins with no capillary bed. Graded Spetzler-Martin I to V.
-
Cavernoma
Cavernous malformation. A raspberry-like cluster of dilated capillaries. Annual haemorrhage risk of around 0.5 to 1.5 per cent.
-
DVA
Developmental venous anomaly. Usually incidental, benign and a normal drainage variant. Not to be resected.
-
dAVF
Dural arteriovenous fistula. Pulsatile tinnitus and haemorrhage risk when cortical veins drain the shunt.
-
Genetics
CCM1, CCM2, CCM3 for familial cavernoma. ENG and ACVRL1 for HHT. RASA1 for CM-AVM. PIK3CA for related overgrowth.
Why this guide matters
Different lesions, different plans.
The name of the lesion matters. Treatment for a DVA is not treatment for an AVM. Getting the diagnosis right is the whole game.
-
Not all lesions need treatment
DVAs and capillary telangiectasias are usually benign incidental findings. Resecting a DVA can cause a venous infarct.
-
MRI first, angiography if needed
MRI with MRA and SWI characterises most lesions. DSA is reserved for AVM and dAVF where treatment planning requires it.
-
A neurovascular MDT is essential
Complex AVM, dAVF, spinal and paediatric cases belong at specialist centres with combined neurosurgery, interventional neuroradiology and radiosurgery on hand.
How the diagnosis is made
From first symptom to a specialist plan.
The steps a UK neurologist, neurosurgeon or interventional neuroradiologist will normally follow.
Phase 1 · Assessing
History, exam and first imaging
Phase 2 · Confirming
Angiography and MDT
Phase 3 · Family
Genetics and surveillance
- 01
Assessing
History and neurological exam
Headache, seizure, focal deficit, pulsatile tinnitus or an incidental scan finding. A careful exam sets the direction.
- 02
Assessing
MRI with MRA and SWI
First-line imaging. Characterises the lesion type and picks up old haemosiderin on susceptibility-weighted sequences.
- 03
Assessing
CT and CTA if acute
For sudden severe headache, suspected haemorrhage or emergency planning. Fast and widely available.
- 04
Confirming
Digital subtraction angiography
DSA is the gold standard for AVM and dAVF. Maps feeders, drainage and haemodynamics for treatment planning.
- 05
Confirming
Neurovascular MDT review
Every complex case is discussed at a specialist centre by neurosurgery, interventional neuroradiology and radiation oncology.
- 06
Family
Genetic testing where indicated
CCM1, CCM2, CCM3 for familial cavernoma. HHT gene panel for suspected hereditary haemorrhagic telangiectasia. RASA1 for CM-AVM.
- 07
Family
Family screening and HHT workup
Cascade testing for relatives. Contrast echo, CT chest and hepatic imaging where HHT is suspected. EEG for seizures.
Typical timeline: urgent for haemorrhage, planned for incidental findings.
Symptoms
How these lesions declare themselves.
From an incidental scan finding to a life-changing bleed, the presentation depends on the lesion type and its location.
-
Incidental finding
Many DVAs, capillary telangiectasias and small cavernomas are picked up on scans done for another reason.
-
Headache
Sudden severe headache raises concern for haemorrhage. Chronic headache alone is rarely due to a vascular malformation.
-
Seizure
A common presentation of cortical cavernoma and AVM. Requires EEG and antiepileptic medication.
-
Focal neurological deficit
Weakness, numbness, speech or vision change. Reflects the location of the lesion or a bleed.
-
Intracerebral or subarachnoid haemorrhage
The feared complication of AVM, cavernoma and high-risk dAVF. An emergency needing neurosurgical assessment.
-
Pulsatile tinnitus
A whooshing sound in time with the pulse is a classic dAVF symptom, especially near the transverse or sigmoid sinus.
-
Neonatal high-output cardiac failure
The presentation of vein of Galen malformation. Needs urgent transfer to a specialist paediatric neurovascular centre.
-
Red flag - thunderclap headache
Sudden worst-ever headache with vomiting or reduced consciousness is a 999 emergency.
Treatment
How these lesions are treated in the UK.
Observation, microsurgery, radiosurgery, embolisation or a combination. Chosen at a neurovascular MDT and matched to the lesion.
-
Observation
Small, incidental and low-risk lesions - DVA, capillary telangiectasia, some cavernomas - are watched with interval MRI rather than treated.
-
Microsurgical resection
Open neurosurgery for accessible AVM, symptomatic cavernoma or high-grade dAVF. Curative when complete.
-
Stereotactic radiosurgery
Gamma Knife or CyberKnife for AVM and select cavernomas. Vessels obliterate over two to three years with millimetre precision.
-
Endovascular embolisation
Catheter delivery of Onyx or coils to occlude AVM feeders, dAVF shunts or vein of Galen malformations. Often staged.
-
Combined multimodal treatment
Complex AVMs may need embolisation to shrink the nidus, then surgery or radiosurgery. Planned at neurovascular MDT.
-
Antiepileptic medication
For seizure control before, during and after definitive treatment. Adjusted to the lesion location and patient factors.
-
Blood pressure control
Tight BP management reduces rebleeding risk and is essential after any haemorrhagic event.
-
Neurorehabilitation
After a bleed or surgery - physiotherapy, occupational therapy, speech and language therapy and neuropsychology.
What this guide is based on
The sources behind every claim on this page.
UK national guidance, specialist society standards and patient charities, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
Your neurologist, neurosurgeon or interventional neuroradiologist knows your scans and history. If in doubt, ask them.
-
NICE. Suspected neurological conditions: recognition and referral (NG127).
-
British Society of Neuroradiologists (BSNR). Guidance on cerebral angiography and neurointervention.
-
Society of British Neurological Surgeons (SBNS). Standards for neurovascular surgery.
-
Cavernoma Alliance UK. Patient information on cerebral cavernous malformations.
-
HHT UK. Hereditary haemorrhagic telangiectasia diagnosis and screening.
Red flags
When to act, and act fast.
Most vascular malformations are managed calmly over weeks. These situations are not - they need immediate attention.
-
Thunderclap headache
Sudden worst-ever headache with vomiting, neck stiffness or reduced consciousness is a 999 emergency for suspected subarachnoid haemorrhage.
-
New focal deficit
Sudden weakness, numbness, speech loss or visual change needs immediate hyperacute stroke assessment.
-
First seizure
A first-ever seizure warrants an urgent brain scan and neurology review to look for a structural cause.
-
Neonatal heart failure with head bruit
A neonate in high-output cardiac failure with a cranial bruit needs urgent transfer for suspected vein of Galen malformation.
-
Pulsatile tinnitus with bruit
Pulsatile tinnitus, especially with an audible bruit, should be investigated for dAVF - not dismissed as benign.
-
Rapidly progressive myelopathy
Progressive leg weakness, sensory level and bladder change may indicate a spinal dAVF - an imaging emergency.
-
Known cavernoma with recurrent bleeds
Two or more symptomatic haemorrhages from the same lesion is an accepted indication for surgical resection.
-
Family history of stroke in the young
A family history of unexplained young stroke or multiple cavernomas warrants genetic counselling.
-
HHT with cerebral symptoms
Any neurological symptom in a person with HHT needs brain and spine MRI to look for AVM and telangiectasia.
Living with it
A long game, with the right team.
Whether the plan is observation or an intervention, four things make the biggest difference year to year.
A quiet reminder
A named specialist team is worth the referral.
Ask which neurovascular MDT is looking after you and how to contact them between appointments.
- 01 Observation
Interval MRI is a plan
Watching a stable, low-risk lesion with scheduled scans is active management, not neglect. Turn up to every appointment.
- 02 Lifestyle
Blood pressure and lifestyle
Keep BP well controlled, avoid smoking and drink within limits. These are the modifiable levers for haemorrhage risk.
- 03 Support
Charities exist for a reason
Cavernoma Alliance UK, HHT UK and the Brain and Spine Foundation offer information, peer support and second opinions.
- 04 Family
Genetics is a family conversation
If a hereditary syndrome is confirmed, cascade testing and reproductive counselling are open to relatives who want them.
Frequently asked
Everything we get asked about CNS vascular malformations.
Quick answers on AVM, cavernoma, DVA, dAVF, vein of Galen and spinal lesions.
-
What is a CNS vascular malformation?
It is an umbrella term for abnormal blood vessels in the brain or spinal cord. The main types are AVM, cavernoma, developmental venous anomaly, capillary telangiectasia, dural arteriovenous fistula and vein of Galen malformation. Each has a different risk profile and treatment path.
-
Do all vascular malformations need treatment?
No. Developmental venous anomalies and most capillary telangiectasias are benign, incidental and left alone. Small unruptured cavernomas and low-grade AVMs are often watched. Symptomatic or high-risk lesions are treated by a specialist neurovascular team.
-
What is the risk of bleeding from a cavernoma?
The annual haemorrhage risk is around 0.5 to 1.5 per cent for an unruptured lesion, and higher after a first bleed or in the brainstem. Familial cavernomatosis and CCM3 mutations carry a higher lifetime risk.
-
What treatments are used for an AVM?
Microsurgical resection, stereotactic radiosurgery with Gamma Knife or CyberKnife, and endovascular embolisation with Onyx. Complex AVMs often need a combination, planned at a neurovascular MDT.
-
Where are these treated in the UK?
Specialist neurovascular centres including Queen Square, King's, Cambridge, Oxford, Newcastle, Sheffield, Manchester, Bristol, Leeds, Edinburgh and Glasgow. Neonatal vein of Galen work is centred on Great Ormond Street, Alder Hey and Bristol.
-
Is genetic testing offered?
Yes, where the clinical picture suggests a familial syndrome. Panels include CCM1, CCM2 and CCM3 for familial cavernoma, ENG and ACVRL1 for HHT and RASA1 for CM-AVM. NHS Genomic Medicine Services coordinate testing and cascade screening.
Related content
Keep reading.
-
Cavernoma
Cerebral cavernous malformation in depth.
Learn more -
Cavernous malformations
A closer look at CCM and familial disease.
Learn more -
Brain AVM
Arteriovenous malformation of the brain.
Learn more -
Arteriovenous malformation
AVM anatomy, grading and treatment options.
Learn more -
Brain aneurysm
Related cerebrovascular condition.
Learn more -
Gamma Knife radiosurgery
Stereotactic radiosurgery for AVM and cavernoma.
Learn more -
Cerebral aneurysm coiling
Endovascular technique used across neurovascular care.
Learn more -
Acquired brain injury rehab
Neurorehabilitation after a bleed or surgery.
Learn more -
Sclerotherapy for veins
Related vascular treatment technique.
Learn more -
Private MRI scan
First-line imaging for vascular malformations.
Learn more -
Whole exome sequencing
Genetic testing for suspected familial lesions.
Learn more -
Private CT scan
For acute haemorrhage and CTA planning.
Learn more